Wedbush Downgrades Prothena Corp (PRTA) to Neutral Amid VITAL Delay
Tweet Send to a Friend
Wedbush downgraded Prothena Corp (NASDAQ: PRTA) from Outperform to Neutral with a price target of $55.00.Analyst David Nierengarten ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
